Use the search parameters below to filter talks:

Calendar
Calendar

2015 - IPITA-IXA-CTS (Melbourne)

Orals: Tolerance, Zoonosis
16 November 2015  /  07:00 - 08:00

Co-stimulation Blockade Inducing Tolerance to Porcine Islet Xenografts Produced Foxp3+ Regulatory T cells with High IL-10 Production and Expressing MHC class II that Were Capable of Dominant Tolerance

Presenter: Min Hu, Westmead, Australia

- Co-stimulation Blockade Inducing Tolerance to Porcine Islet Xenografts Produced Foxp3+ Regulatory T cells with High IL-10 Production and Expressing MHC class II that Were Capable of Dominant Tolerance

Presenter: Min Hu, Westmead, Australia

ABO-tolerance in a murine model of ABO-incompatible heart transplantation (ABOi HTx)

Presenter: Lori West, Edmonton, Canada

- ABO-tolerance in a murine model of ABO-incompatible heart transplantation (ABOi HTx)

Presenter: Lori West, Edmonton, Canada

Cryopreserved regulatory T cells (Tregs) isolated from discarded human thymus potently suppress allogeneic and xenogeneic immune responses after expansion

Presenter: Esme Dijke, Edmonton, Canada

- Cryopreserved regulatory T cells (Tregs) isolated from discarded human thymus potently suppress allogeneic and xenogeneic immune responses after expansion

Presenter: Esme Dijke, Edmonton, Canada

Microbiological screening of wild-type and genetically engineered pigs and transplant recipients in pig to non-human primate xenotransplantation

Presenter: Joachim Denner, Berlin, Germany

- Microbiological screening of wild-type and genetically engineered pigs and transplant recipients in pig to non-human primate xenotransplantation

Presenter: Joachim Denner, Berlin, Germany

Antibody studies using virus particles displaying xeno-reactive antigens; alpha-Gal, Neu5Gc and SDa-like carbohydrate structures

Presenter: Yasuhiro Takeuchi, London, United Kingdom

- Antibody studies using virus particles displaying xeno-reactive antigens; alpha-Gal, Neu5Gc and SDa-like carbohydrate structures

Presenter: Yasuhiro Takeuchi, London, United Kingdom

Impact of PERV infection on the pig transcriptome

Presenter: Ralf Tönjes, Langen, Germany

- Impact of PERV infection on the pig transcriptome

Presenter: Ralf Tönjes, Langen, Germany

Cell & Tissue Xenotransplantation: Tolerance
17 November 2015  /  07:00 - 08:00

Clinical trial of acellular porcine corneal matrix in the treatment of corneal ulcer

Presenter: Zhiqiang Pan, Beijing, People's Republic of China

- Clinical trial of acellular porcine corneal matrix in the treatment of corneal ulcer

Presenter: Zhiqiang Pan, Beijing, People's Republic of China

Effect and safety of anti-CD40 antibody on the survival of corneal xenotransplantation

Presenter: Jaeyoung Kim, Seoul, Korea

- Effect and safety of anti-CD40 antibody on the survival of corneal xenotransplantation

Presenter: Jaeyoung Kim, Seoul, Korea

Experimental study on GTKO/CD46 Pig-to-Rhesus corneal xenotransplantation

Presenter: Xiaojuan Dong, Beijing, People's Republic of China

- Experimental study on GTKO/CD46 Pig-to-Rhesus corneal xenotransplantation

Presenter: Xiaojuan Dong, Beijing, People's Republic of China

Human tolerogenic dendritic cells partially inhibit xenogeneic NK and CD8+ T cell responses in vitro

Presenter: Natacha Madelon, Geneva, Switzerland

- Human tolerogenic dendritic cells partially inhibit xenogeneic NK and CD8+ T cell responses in vitro

Presenter: Natacha Madelon, Geneva, Switzerland

Foxp3+ regulatory T cells are essential for the induction and maintenance of tolerance to neonatal porcine islet cell cluster xenografts induced by co-stimulatory blockade

Presenter: Yi Wen Qian, Sydney, Australia

- Foxp3+ regulatory T cells are essential for the induction and maintenance of tolerance to neonatal porcine islet cell cluster xenografts induced by co-stimulatory blockade

Presenter: Yi Wen Qian, Sydney, Australia

Pancreas Transplantation: Global Trends in Pancreas Transplantation – challenges and opportunities
15 November 2015  /  13:00 - 16:15

Global trends in Pancreas Transplantation – Regional reports: Introduction

Presenter: Raja Kandaswamy, Minneapolis, United States

- Global trends in Pancreas Transplantation – Regional reports: Introduction

Presenter: Raja Kandaswamy, Minneapolis, United States

Global trends in Pancreas Transplantation – Regional reports: North America

Presenter: Angelika Gruessner, Tucson, United States

- Global trends in Pancreas Transplantation – Regional reports: North America

Presenter: Angelika Gruessner, Tucson, United States

Global trends in Pancreas Transplantation – Regional reports: Europe

Presenter: Peter Friend, Oxford, United Kingdom

- Global trends in Pancreas Transplantation – Regional reports: Europe

Presenter: Peter Friend, Oxford, United Kingdom

Global trends in Pancreas Transplantation – Regional reports: Australia

Presenter: Henry Pleass, Westmead, Australia

- Global trends in Pancreas Transplantation – Regional reports: Australia

Presenter: Henry Pleass, Westmead, Australia

Global trends in Pancreas Transplantation – Regional reports: South America

Presenter: Pablo Uva, Buenos Aires, Argentina

- Global trends in Pancreas Transplantation – Regional reports: South America

Presenter: Pablo Uva, Buenos Aires, Argentina

Global trends in Pancreas Transplantation – Regional reports: Asia

Presenter: Duck Jong Han, Seoul, Korea

- Global trends in Pancreas Transplantation – Regional reports: Asia

Presenter: Duck Jong Han, Seoul, Korea

Challenges: Advances in Diabetic Rx

Presenter: Thomas Kay, Frizroy, Australia

- Challenges: Advances in Diabetic Rx

Presenter: Thomas Kay, Frizroy, Australia

Challenges: Impact of Pancreas Transplantation on survival – patient and kidney graft

Presenter: Jonathan Fridell, Indianapolis, United States

- Challenges: Impact of Pancreas Transplantation on survival – patient and kidney graft

Presenter: Jonathan Fridell, Indianapolis, United States

Challenges: Emerging therapies

Presenter: Thierry Berney, Geneva, Switzerland

- Challenges: Emerging therapies

Presenter: Thierry Berney, Geneva, Switzerland

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi